| Applications and limitations of dendrimers in biomedicine AA Chis, C Dobrea, C Morgovan, AM Arseniu, LL Rus, A Butuca, ... Molecules 25 (17), 3982, 2020 | 517 | 2020 |
| Advantages of hyaluronic acid and its combination with other bioactive ingredients in cosmeceuticals AM Juncan, DG Moisă, A Santini, C Morgovan, LL Rus, AL Vonica-Țincu, ... Molecules 26 (15), 4429, 2021 | 422 | 2021 |
| Microbial resistance to antibiotics and effective antibiotherapy AA Chiș, LL Rus, C Morgovan, AM Arseniu, A Frum, AL Vonica-Țincu, ... Biomedicines 10 (5), 1121, 2022 | 107 | 2022 |
| The particularities of pharmaceutical care in improving public health service during the COVID-19 pandemic S Ghibu, AM Juncan, LL Rus, A Frum, CM Dobrea, AA Chiş, FG Gligor, ... International journal of environmental research and public health 18 (18), 9776, 2021 | 50 | 2021 |
| High-throughput NIR-chemometric methods for determination of drug content and pharmaceutical properties of indapamide tablets I Tomuta, L Rus, R Iovanov, LL Rus Journal of Pharmaceutical and Biomedical Analysis 84, 285-292, 2013 | 47 | 2013 |
| Nutrivigilance: A new activity in the field of dietary supplements C Morgovan, S Ghibu, AM Juncan, LL Rus, A Butucă, L Vonica, ... Farmacia 67 (3), 537-544, 2019 | 46 | 2019 |
| Dendrimers as non-viral vectors in gene-directed enzyme prodrug therapy AA Chis, CM Dobrea, LL Rus, A Frum, C Morgovan, A Butuca, M Totan, ... Molecules 26 (19), 5976, 2021 | 37 | 2021 |
| Assesment of synovial fluid pH in osteoarthritis of the HIP and knee MD Roman, RS Fleaca, A Boicean, D Bratu, V Birlutiu, LL Rus, C Tantar, ... Rev. Chim 68 (6), 1242-1244, 2017 | 33 | 2017 |
| A Pharmacovigilance Study Regarding the Risk of Antibiotic-Associated Clostridioides difficile Infection Based on Reports from the EudraVigilance Database … BI Vintila, AM Arseniu, C Morgovan, A Butuca, M Sava, V Bîrluțiu, LL Rus, ... Pharmaceuticals 16 (11), 1585, 2023 | 32 | 2023 |
| Valorization of grape pomace and berries as a new and sustainable dietary supplement: development, characterization, and antioxidant activity testing A Frum, CM Dobrea, LL Rus, LI Virchea, C Morgovan, AA Chis, ... Nutrients 14 (15), 3065, 2022 | 30 | 2022 |
| Adverse drug reactions relevant to drug resistance and ineffectiveness associated with meropenem, linezolid, and colistin: an analysis based on spontaneous reports from the … BI Vintila, AM Arseniu, A Butuca, M Sava, V Bîrluțiu, LL Rus, DD Axente, ... Antibiotics 12 (5), 918, 2023 | 27 | 2023 |
| An exploratory research of 18 years on the economic burden of diabetes for the Romanian National Health Insurance System C Morgovan, SA Cosma, M Valeanu, AM Juncan, LL Rus, FG Gligor, ... International Journal of Environmental Research and Public Health 17 (12), 4456, 2020 | 25 | 2020 |
| Development and evaluation of a novel anti-ageing cream based on hyaluronic acid and other innovative cosmetic actives AM Juncan, C Morgovan, LL Rus, F Loghin Polymers 15 (20), 4134, 2023 | 23 | 2023 |
| Antibody–drug conjugates—evolution and perspectives AA Chis, CM Dobrea, AM Arseniu, A Frum, LL Rus, G Cormos, ... International Journal of Molecular Sciences 25 (13), 6969, 2024 | 22 | 2024 |
| A descriptive analysis of direct oral anticoagulant drugs dosing errors based on spontaneous reports from the EudraVigilance database C Morgovan, CM Dobrea, AA Chis, AM Juncan, AM Arseniu, LL Rus, ... Pharmaceuticals 16 (3), 455, 2023 | 22 | 2023 |
| Biopolymeric prodrug systems as potential antineoplastic therapy AA Chis, AM Arseniu, C Morgovan, CM Dobrea, A Frum, AM Juncan, ... Pharmaceutics 14 (9), 1773, 2022 | 21 | 2022 |
| A Real-World Study on the Clinical Characteristics, Outcomes, and Relationship between Antibiotic Exposure and Clostridioides difficile Infection BI Vintila, AM Arseniu, C Morgovan, A Butuca, V Bîrluțiu, CM Dobrea, ... Antibiotics 13 (2), 144, 2024 | 17 | 2024 |
| Some Brassicaceae Extracts as Potential Antioxidants and Green Corrosion Inhibitors IMC Ienașcu, A Căta, AA Chis, MN Ştefănuț, P Sfîrloagă, G Rusu, ... Materials 16 (8), 2967, 2023 | 16 | 2023 |
| An assessment of semaglutide safety based on real world data: from popularity to spontaneous reporting in Eudravigilance database A Butuca, CM Dobrea, AM Arseniu, A Frum, AA Chis, LL Rus, S Ghibu, ... Biomedicines 12 (5), 1124, 2024 | 15 | 2024 |
| Safety profile of the trastuzumab-based ADCs: analysis of real-world data registered in EudraVigilance C Morgovan, CM Dobrea, A Butuca, AM Arseniu, A Frum, LL Rus, AA Chis, ... Biomedicines 12 (5), 953, 2024 | 15 | 2024 |
